RemeGen Statistics

Total Valuation

RemeGen has a market cap or net worth of HKD 76.34 billion. The enterprise value is 76.10 billion.

Market Cap	76.34B
Enterprise Value	76.10B

Important Dates

The last earnings date was Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	n/a

Share Statistics

RemeGen has 559.97 million shares outstanding. The number of shares has increased by 2.28% in one year.

Current Share Class	204.27M
Shares Outstanding	559.97M
Shares Change (YoY)	+2.28%
Shares Change (QoQ)	+2.22%
Owned by Insiders (%)	11.87%
Owned by Institutions (%)	29.34%
Float	344.63M

Valuation Ratios

The trailing PE ratio is 72.80 and the forward PE ratio is 14.52.

PE Ratio	72.80
Forward PE	14.52
PS Ratio	21.10
PB Ratio	19.01
P/TBV Ratio	19.85
P/FCF Ratio	n/a
P/OCF Ratio	1,295.55
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 152.17, with an EV/FCF ratio of -465.01.

EV / Earnings	96.36
EV / Sales	21.03
EV / EBITDA	152.17
EV / EBIT	n/a
EV / FCF	-465.01

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.61.

Current Ratio	1.43
Quick Ratio	1.16
Debt / Equity	0.61
Debt / EBITDA	4.90
Debt / FCF	-14.97
Interest Coverage	1.99

Financial Efficiency

Return on equity (ROE) is 25.37% and return on invested capital (ROIC) is 4.16%.

Return on Equity (ROE)	25.37%
Return on Assets (ROA)	1.37%
Return on Invested Capital (ROIC)	4.16%
Return on Capital Employed (ROCE)	3.14%
Weighted Average Cost of Capital (WACC)	6.81%
Revenue Per Employee	1.19M
Profits Per Employee	259,090
Employee Count	3,048
Asset Turnover	0.51
Inventory Turnover	0.63

Taxes

In the past 12 months, RemeGen has paid 833,151 in taxes.

Income Tax	833,151
Effective Tax Rate	0.11%

Stock Price Statistics

The stock price has increased by +140.51% in the last 52 weeks. The beta is 0.49, so RemeGen's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	+140.51%
50-Day Moving Average	94.38
200-Day Moving Average	87.71
Relative Strength Index (RSI)	50.03
Average Volume (20 Days)	5,011,774

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RemeGen had revenue of HKD 3.62 billion and earned 789.71 million in profits. Earnings per share was 1.44.

Revenue	3.62B
Gross Profit	3.16B
Operating Income	155.64M
Pretax Income	790.54M
Net Income	789.71M
EBITDA	436.16M
EBIT	155.64M
Earnings Per Share (EPS)	1.44

Full Income Statement

Balance Sheet

The company has 2.70 billion in cash and 2.45 billion in debt, giving a net cash position of 245.62 million or 0.44 per share.

Cash & Cash Equivalents	2.70B
Total Debt	2.45B
Net Cash	245.62M
Net Cash Per Share	0.44
Equity (Book Value)	4.02B
Book Value Per Share	7.18
Working Capital	1.33B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 58.93 million and capital expenditures -222.57 million, giving a free cash flow of -163.64 million.

Operating Cash Flow	58.93M
Capital Expenditures	-222.57M
Depreciation & Amortization	288.93M
Net Borrowing	-170.04M
Free Cash Flow	-163.64M
FCF Per Share	-0.29

Full Cash Flow Statement

Margins

Gross margin is 87.22%, with operating and profit margins of 4.30% and 21.83%.

Gross Margin	87.22%
Operating Margin	4.30%
Pretax Margin	21.85%
Profit Margin	21.83%
EBITDA Margin	12.06%
EBIT Margin	4.30%
FCF Margin	n/a

Dividends & Yields

RemeGen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	10.15%
Buyback Yield	-2.28%
Shareholder Yield	-2.28%
Earnings Yield	1.03%
FCF Yield	-0.21%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RemeGen has an Altman Z-Score of 5.54 and a Piotroski F-Score of 7.

Altman Z-Score	5.54
Piotroski F-Score	7